Nicholas Augustinos - Oct 29, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Nicholas Augustinos
Stock symbol
DXCM
Transactions as of
Oct 29, 2021
Transactions value $
-$1,500,087
Form type
4
Date filed
11/2/2021, 05:12 PM
Previous filing
Jun 7, 2021
Next filing
May 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$1.5M -2.5K -73.14% $600.03 918 Oct 29, 2021 Direct F1, F2, F3
holding DXCM Common Stock 7.59K Oct 29, 2021 by Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.
F2 This transaction was executed in multiple trades at prices ranging from $600.00 to $600.295. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.